• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

FDA approves SetPoint neuroimmune modulation device for rheumatoid arthritis

August 8, 2025
in Medical Research
Reading Time: 2 mins read
A A
0
Fda approves SetPoint neuroimmune modulation device for rheumatoid arthritis
3
SHARES
6
VIEWS
Share on FacebookShare on Twitter


Fda approves SetPoint neuroimmune modulation device for rheumatoid arthritis

The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA).

The SetPoint System is indicated for patients who are not adequately managed by—or cannot tolerate—existing advanced RA therapies, such as biological and targeted synthetic disease-modifying antirheumatic drugs (DMARDs).

The SetPoint System is an implantable, integrated neurostimulation device that delivers electrical stimulation to the vagus nerve, once daily, and is intended to activate the body’s innate anti-inflammatory and immune-restorative pathways.

The approval is supported by the results of the RESET-RA study, in which 242 patients were randomly assigned to the SetPoint System or a sham device.

The trial met its primary efficacy end point of American College of Rheumatology 20% improvement at three months, with improvements seen for response rates and disease activity metrics through 12 months of follow-up. Three-fourths of participants were free of biologic or targeted synthetic DMARDs at 12 months. The device placement procedure and stimulation therapy were well tolerated, with a 1.7% rate of related serious adverse events.

“The approval of the SetPoint System highlights the potential of neuroimmune modulation as a novel approach for autoimmune disease, by harnessing the body’s neural pathways to combat inflammation,” the principal investigator in the RESET-RA study, Mark Richardson, M.D., Ph.D., from Harvard University in Boston, said in a statement.

“After implantation during a minimally invasive outpatient procedure, the SetPoint device is programmed to automatically administer therapy on a predetermined schedule for up to 10 years, simplifying care for people living with RA.”

Approval of the SetPoint device was granted to SetPoint Medical.

Copyright © 2025 HealthDay. All rights reserved.

Citation:
FDA approves SetPoint neuroimmune modulation device for rheumatoid arthritis (2025, August 8)
retrieved 8 August 2025
from https://medicalxpress.com/news/2025-08-fda-setpoint-neuroimmune-modulation-device.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




Fda approves SetPoint neuroimmune modulation device for rheumatoid arthritis

The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA).

The SetPoint System is indicated for patients who are not adequately managed by—or cannot tolerate—existing advanced RA therapies, such as biological and targeted synthetic disease-modifying antirheumatic drugs (DMARDs).

The SetPoint System is an implantable, integrated neurostimulation device that delivers electrical stimulation to the vagus nerve, once daily, and is intended to activate the body’s innate anti-inflammatory and immune-restorative pathways.

The approval is supported by the results of the RESET-RA study, in which 242 patients were randomly assigned to the SetPoint System or a sham device.

The trial met its primary efficacy end point of American College of Rheumatology 20% improvement at three months, with improvements seen for response rates and disease activity metrics through 12 months of follow-up. Three-fourths of participants were free of biologic or targeted synthetic DMARDs at 12 months. The device placement procedure and stimulation therapy were well tolerated, with a 1.7% rate of related serious adverse events.

“The approval of the SetPoint System highlights the potential of neuroimmune modulation as a novel approach for autoimmune disease, by harnessing the body’s neural pathways to combat inflammation,” the principal investigator in the RESET-RA study, Mark Richardson, M.D., Ph.D., from Harvard University in Boston, said in a statement.

“After implantation during a minimally invasive outpatient procedure, the SetPoint device is programmed to automatically administer therapy on a predetermined schedule for up to 10 years, simplifying care for people living with RA.”

Approval of the SetPoint device was granted to SetPoint Medical.

Copyright © 2025 HealthDay. All rights reserved.

Citation:
FDA approves SetPoint neuroimmune modulation device for rheumatoid arthritis (2025, August 8)
retrieved 8 August 2025
from https://medicalxpress.com/news/2025-08-fda-setpoint-neuroimmune-modulation-device.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

Texas Gov. Greg Abbott moves to amp up the pressure on Democrats who fled in redistricting standoff

Next Post

Trump to preside over Armenia-Azerbaijan peace framework, upstaging Russia

Related Posts

Budgeting for Medical Bills: Protecting Your Financial Health

August 8, 2025
5
New insights into how the visual system synchronizes visual information

How the retina synchronizes different visual signals regardless of their speed

August 8, 2025
9
Next Post

Trump to preside over Armenia-Azerbaijan peace framework, upstaging Russia

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Police ID man who died after Corso Italia fight

December 23, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
In disaster-prone Vanuatu, photos show sea animals returning to battered reefs. Can recovery happen?

In disaster-prone Vanuatu, photos show sea animals returning to battered reefs. Can recovery happen?

August 8, 2025

Budgeting for Medical Bills: Protecting Your Financial Health

August 8, 2025
kristi noem dhs video ice

ICE is leaning hard on recruitment, but immigration experts say that could come at a price

August 8, 2025
Democratic Detroit lawmaker Joe Tate drops out of US Senate race

Democratic Detroit lawmaker Joe Tate drops out of US Senate race

August 8, 2025

Recent News

In disaster-prone Vanuatu, photos show sea animals returning to battered reefs. Can recovery happen?

In disaster-prone Vanuatu, photos show sea animals returning to battered reefs. Can recovery happen?

August 8, 2025
2

Budgeting for Medical Bills: Protecting Your Financial Health

August 8, 2025
5
kristi noem dhs video ice

ICE is leaning hard on recruitment, but immigration experts say that could come at a price

August 8, 2025
3
Democratic Detroit lawmaker Joe Tate drops out of US Senate race

Democratic Detroit lawmaker Joe Tate drops out of US Senate race

August 8, 2025
3

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

In disaster-prone Vanuatu, photos show sea animals returning to battered reefs. Can recovery happen?

In disaster-prone Vanuatu, photos show sea animals returning to battered reefs. Can recovery happen?

August 8, 2025

Budgeting for Medical Bills: Protecting Your Financial Health

August 8, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co